• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Analysis of malignant pleural mesothelioma invasion using laser-proteomics

Research Project

Project/Area Number 16K10703
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Respiratory surgery
Research InstitutionHiroshima University

Principal Investigator

Miyata Yoshihiro  広島大学, 原爆放射線医科学研究所, 准教授 (50397965)

Project Period (FY) 2016-04-01 – 2019-03-31
Project Status Completed (Fiscal Year 2018)
Budget Amount *help
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2018: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2017: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2016: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Keywords悪性胸膜中皮腫 / レーザープロテオミクス / 次世代シークエンサー
Outline of Final Research Achievements

We used laser-proteomics and laser-microdissection to identify molecules involved in the micro-invasion of Malignant Pleural Mesothelioma (MPM).
RNA was extracted from the invasive area and non-invasive area from the MPM sample, and a comprehensive gene analysis was performed. BAP1, NF2, NOTCH1, ABL1, ATM, CDKN2A, ERBB2, FBXW7, PTEN were identified as candidate genes from 12 samples. Furthermore, we decided the molecules (Noxa, MUC4, DAB2, Intelectin-1, Glypican-1, Survivin, BAP1, Mucin 21), which could differentiate MPM from lung adenocarcinoma and confirmed their clinical relevances.

Academic Significance and Societal Importance of the Research Achievements

アスベスト暴露に起因し近年社会問題化している悪性胸膜中皮腫(MPM)は、早期発見が難しく、その治療性成績は極めて悪い。そのため早期診断や新規治療薬の開発による予後改善が急務である。今回MPM浸潤成分特異的分子、及び肺腺癌との鑑別に有用な分子を同定できたことにより、MPMの浸潤メカニズムの一部が解明された。これによりMPMの早期確定期診断が可能となり、手術等による局所治療介入による予後改善が期待できる。更に同定された分子を制御する機序解析を進めることにより、新規分子標的治療薬開発につながることが期待される。

Report

(4 results)
  • 2018 Annual Research Report   Final Research Report ( PDF )
  • 2017 Research-status Report
  • 2016 Research-status Report
  • Research Products

    (3 results)

All 2019

All Journal Article (3 results) (of which Peer Reviewed: 3 results,  Open Access: 3 results)

  • [Journal Article] Metachronous Lung Cancer After Pleurectomy/Decortication2019

    • Author(s)
      Kai Y, Tsutani Y, Ito M, Mimura T, Miyata Y, Okada M.
    • Journal Title

      Ann Thorac Surg

      Volume: 107 Issue: 1 Pages: e1-e3

    • DOI

      10.1016/j.athoracsur.2018.05.087

    • Related Report
      2018 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Prolonged post-recurrence survival following pleurectomy/decortication for malignant pleural mesothelioma2019

    • Author(s)
      Kai Y, Tsutani Y, Tsubokawa N, Ito M, Mimura T, Miyata Y, Okada M.
    • Journal Title

      Oncol Lett

      Volume: 17 Pages: 3607-3614

    • DOI

      10.3892/ol.2019.9979

    • Related Report
      2018 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Mucin 21 is a novel, negative immunohistochemical marker for epithelioid mesothelioma for its differentiation from lung adenocarcinoma2019

    • Author(s)
      Kai Yuichiro、Amatya Vishwa J、Kushitani Kei、Kambara Takahiro、Suzuki Rui、Tsutani Yasuhiro、Miyata Yoshihiro、Okada Morihito、Takeshima Yukio
    • Journal Title

      Histopathology

      Volume: 74 Issue: 4 Pages: 545-554

    • DOI

      10.1111/his.13775

    • Related Report
      2018 Annual Research Report
    • Peer Reviewed / Open Access

URL: 

Published: 2016-04-21   Modified: 2020-03-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi